US consumer groups allege misleading drug claimsBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7310.415 (Published 25 August 2001) Cite this as: BMJ 2001;323:415
- Scott Gottlieb
- New York
A coalition of US consumer groups has filed a lawsuit against Schering-Plough, the manufacturer of the allergy drug Claritin (loratadine), claiming that the company falsely advertises the benefits of the medicine.
The Boston based coalition, known as the Prescription Access Litigation project, filed a class action lawsuit accusing the drug manufacturer of misrepresenting Claritin in its advertising—causing increased demand for the drug—and of artificially inflating its price. The complaint alleges that Schering-Plough's advertising of the drug …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial